Gaucher's disease (patient information): Difference between revisions

Jump to navigation Jump to search
Raviteja Reddy Guddeti (talk | contribs)
No edit summary
Raviteja Reddy Guddeti (talk | contribs)
No edit summary
 
Line 1: Line 1:
__NOTOC__
{{Gaucher's disease (patient information)}}
'''For the WikiDoc page for this topic, click [[Gaucher's disease|here]]'''
'''For the WikiDoc page for this topic, click [[Gaucher's disease|here]]'''
{{SI}}
 
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Varun Kumar]], M.B.B.S.
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Varun Kumar]], M.B.B.S.



Latest revision as of 04:05, 28 August 2012

Gaucher's disease

Overview

What are the symptoms?

What are the causes?

Who is at highest risk?

Diagnosis

When to seek urgent medical care?

Treatment options

Where to find medical care for Gaucher's disease?

Prevention

What to expect (Outlook/Prognosis)?

Possible complications

Gaucher's disease On the Web

Ongoing Trials at Clinical Trials.gov

Images of Gaucher's disease

Videos on Gaucher's disease

FDA on Gaucher's disease

CDC on Gaucher's disease

Gaucher's diseasein the news

Blogs on Gaucher's disease

Directions to Hospitals Treating Gaucher's disease

Risk calculators and risk factors for Gaucher's disease

For the WikiDoc page for this topic, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S.

Overview

Gaucher disease is a rare genetic disorder in which a person lacks an enzyme called glucocerebrosidase.

What are the symptoms of Gaucher's disease?

Symptoms vary depending on the type of disease, but may include:

What causes Gaucher's disease?

The lack of the glucocerebrosidase enzyme causes harmful substances to build up in the liver, spleen, bones, and bone marrow. The substances prevent cells and organs from working properly.

There are three main subtypes of Gaucher disease:

  • Type 1 disease is most common. It involves bone disease, anemia, an enlarged spleen and thrombocytopenia. Type I affects both children and adults. It is most common in the Ashkenazi Jewish population.
  • Type 2 disease usually begins in infancy with severe neurologic involvement. This form can lead to rapid, early death.
  • Type 3 disease may cause liver, spleen, and brain problems. Patients may live into adulthood.

Who is at the highest risk?

Gaucher disease affects an estimated 1 in 50,000 to 1 in 100,000 people in the general population. Persons of Eastern and Central European (Ashkenazi) Jewish heritage are at highest risk for the disease.

It is an autosomal recessive disease. This means that the mother and father must both pass one abnormal copy of the gene to the child in order for the child to develop the disease. A parent who silently carries an abnormal copy of the gene is called a carrier.

Diagnosis

The doctor will perform a physical exam. The patient may have signs of liver and spleen swelling, bone changes, lung disease, eye movement problems, heart problems, or hearing loss.

The following tests may be performed:

  • Blood test to look for enzyme activity
  • Bone marrow aspiration
  • Biopsy of the spleen
  • MRI
  • CT
  • X-ray of the skeleton
  • Genetic testing

Treatment options

Enzyme replacement therapy is available. A bone marrow transplant may be needed in severe cases.

Where to find medical care for Gaucher's disease?

Directions to Hospitals Treating Gaucher's disease

What to expect (Outlook/Prognosis)?

How well a person does depends on the subtype of the disease. The infantile form of Gaucher disease may lead to early death. Most affected children die before age 5.

Adults with the type 1 form of the disease can expect normal life expectancy with enzyme replacement therapy.

Possible complications

Sources

http://www.nlm.nih.gov/medlineplus/ency/article/000564.htm


Template:WikiDoc Sources